Xiaofu Qiu
Overview
Explore the profile of Xiaofu Qiu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
252
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xiong X, Liu J, Wu X, Yao Z, Meng Y, Liu S, et al.
Sci Rep
. 2025 Feb;
15(1):7065.
PMID: 40016288
Lung metastasis is the primary cause of breast cancer-related mortality. Protein tyrosine phosphatases such as PTPRO are important in cancer progression. However, the role and underlying mechanisms of PTPRO in...
2.
Zheng Z, Dai F, Liu J, Zhang Y, Wang Z, Wang B, et al.
BMC Cancer
. 2025 Feb;
25(1):310.
PMID: 39979837
Background: Bladder cancer (BLCA) exists a profound molecular diversity, with basal and luminal subtypes having different prognostic and therapeutic outcomes. Traditional methods for molecular subtyping are often time-consuming and resource-intensive....
3.
Wang K, Cao Z, Wang W, Yang C, Xu H, Yang Y, et al.
BMC Urol
. 2024 Dec;
24(1):274.
PMID: 39709413
Background: Here, we aim to develop and validate a viable prognostic nomogram model for predicting a stone-free rate of kidney stones patients based on retrospective cohort analysis. Methods: This is...
4.
Han S, Wang M, Wang Y, Wu J, Guo Z, Wang H, et al.
Cell Rep Med
. 2024 Dec;
5(12):101870.
PMID: 39657665
Overbiopsy is a serious health issue in prostate cancer (PCa) diagnostics. We have developed a urine tumor DNA multidimensional bioinformatic algorithm, utLIFE, to avoid unnecessary biopsy. The objective is to...
5.
Feng X, Wang Z, Cen M, Zheng Z, Wang B, Zhao Z, et al.
Biofactors
. 2024 Nov;
51(1):e2143.
PMID: 39614426
Renal clear cell carcinoma (ccRCC) is a highly aggressive and common form of kidney cancer, with limited treatment options for advanced stages. Recent studies have highlighted the importance of the...
6.
Lai W, Zhu W, Wu J, Huang J, Li X, Luo Y, et al.
Redox Biol
. 2024 Oct;
77:103392.
PMID: 39405980
Ferroptosis induction has emerged as a promising therapeutic approach for prostate cancer (PCa), either as a monotherapy or in combination with hormone therapy. Therefore, identifying the mechanisms regulating ferroptosis in...
7.
Xu H, Wang K, Cao Z, Wang W, Yang C, Yang Y, et al.
Transl Androl Urol
. 2024 Jun;
13(5):667-678.
PMID: 38855606
Background: Urosepsis is a serious complication after percutaneous nephrolithotomy (PCNL). This study aimed to develop and validate a nomogram model that can effectively predict urosepsis following PCNL. Methods: A total...
8.
Wang Z, Zheng Z, Wang B, Zhan C, Yuan X, Lin X, et al.
Heliyon
. 2024 Apr;
10(7):e29289.
PMID: 38617927
Clear cell renal cell carcinoma (ccRCC) presents challenges in early diagnosis and effective treatment. In this study, we aimed to establish a prognostic model based on G2M checkpoint-related genes and...
9.
Yao Z, Dong H, Zhu J, Du L, Luo Y, Liu Q, et al.
JCI Insight
. 2023 Jul;
8(14).
PMID: 37485875
Chemotherapy-related cognitive impairment (CRCI) or "chemo brain" is a devastating neurotoxic sequela of cancer-related treatments, especially for the elderly individuals. Here we show that PTPRO, a tyrosine phosphatase, is highly...
10.
Li K, Lin Y, Zhou Y, Xiong X, Wang L, Li J, et al.
Gastroenterology
. 2023 Jul;
165(4):932-945.e9.
PMID: 37399999
Background & Aims: Early detection of esophageal squamous cell carcinoma (ESCC) will facilitate curative treatment. We aimed to establish a microRNA (miRNA) signature derived from salivary extracellular vesicles and particles...